Members |
acceptabilityId |
11 beta-hydroxylase |
Acceptable (foundation metadata concept) |
11 cis-Eicosenoic acid |
Preferred (foundation metadata concept) |
11 cis-Eicosenoic acid (substance) |
Preferred (foundation metadata concept) |
11 o'clock position |
Preferred (foundation metadata concept) |
11 o'clock position (qualifier value) |
Preferred (foundation metadata concept) |
11 o'clock position on mammogram |
Preferred (foundation metadata concept) |
11 o'clock position on mammogram (finding) |
Preferred (foundation metadata concept) |
11,17,18,21-tetrahydroxypregn-4-ene-3,20-dione |
Acceptable (foundation metadata concept) |
11-C |
Acceptable (foundation metadata concept) |
11-Deoxy, 17-hydroxycorticosterone |
Preferred (foundation metadata concept) |
11-Deoxy, 17-hydroxycorticosterone (substance) |
Preferred (foundation metadata concept) |
11-Deoxy/11-oxysteroids measurement |
Preferred (foundation metadata concept) |
11-Deoxy/11-oxysteroids measurement (procedure) |
Preferred (foundation metadata concept) |
11-Deoxycorticosterone |
Preferred (foundation metadata concept) |
11-Deoxycorticosterone (substance) |
Preferred (foundation metadata concept) |
11-O-demethyl-17-O-deacetylvindoline O-methyltransferase |
Preferred (foundation metadata concept) |
11-O-demethyl-17-O-deacetylvindoline O-methyltransferase (substance) |
Preferred (foundation metadata concept) |
11-Oxopregnanetriol measurement |
Preferred (foundation metadata concept) |
11-Oxopregnanetriol measurement (procedure) |
Preferred (foundation metadata concept) |
11-Oxy fraction of 17-KS |
Preferred (foundation metadata concept) |
11-Oxy fraction of 17-KS (substance) |
Preferred (foundation metadata concept) |
11-Oxycorticosterone |
Preferred (foundation metadata concept) |
11-Oxycorticosterone (substance) |
Preferred (foundation metadata concept) |
11-beta hydroxyandrostenedione |
Preferred (foundation metadata concept) |
11-beta hydroxyandrostenedione (substance) |
Preferred (foundation metadata concept) |
11-beta,18,21-trihydroxypregn-4-ene-3,20-dione |
Acceptable (foundation metadata concept) |
11-beta-hydroxylase deficiency |
Acceptable (foundation metadata concept) |
11-beta-hydroxysteroid dehydrogenase |
Preferred (foundation metadata concept) |
11-beta-hydroxysteroid dehydrogenase (substance) |
Preferred (foundation metadata concept) |
11-beta-hydroxysteroid dehydrogenase deficiency type 1 |
Acceptable (foundation metadata concept) |
11-beta-hydroxysteroid dehydrogenase deficiency type 2 |
Acceptable (foundation metadata concept) |
11-cis-retinyl-palmitate hydrolase |
Preferred (foundation metadata concept) |
11-cis-retinyl-palmitate hydrolase (substance) |
Preferred (foundation metadata concept) |
11-dehydro thromboxane beta 2 |
Preferred (foundation metadata concept) |
11-dehydro thromboxane beta 2 (substance) |
Preferred (foundation metadata concept) |
11-dehydrocorticosterone |
Acceptable (foundation metadata concept) |
11-dehydrotetrahydrocorticosterone |
Preferred (foundation metadata concept) |
11-dehydrotetrahydrocorticosterone (substance) |
Preferred (foundation metadata concept) |
11-deoxy steroid |
Acceptable (foundation metadata concept) |
11-deoxy, 17-hydroxycorticosterone |
Acceptable (foundation metadata concept) |
11-deoxy, 17-hydroxycorticosterone level above reference range |
Preferred (foundation metadata concept) |
11-deoxy, 17-hydroxycorticosterone level above reference range (finding) |
Preferred (foundation metadata concept) |
11-deoxy, 17-hydroxycorticosterone level below reference range |
Preferred (foundation metadata concept) |
11-deoxy, 17-hydroxycorticosterone level below reference range (finding) |
Preferred (foundation metadata concept) |
11-deoxy, 17-hydroxycorticosterone within reference range |
Preferred (foundation metadata concept) |
11-deoxy, 17-hydroxycorticosterone within reference range (finding) |
Preferred (foundation metadata concept) |
11-deoxy-17-ketosteroid |
Preferred (foundation metadata concept) |
11-deoxy-17-ketosteroid (substance) |
Preferred (foundation metadata concept) |
11-deoxycorticosteroids challenge tests |
Preferred (foundation metadata concept) |
11-deoxycorticosteroids challenge tests (procedure) |
Preferred (foundation metadata concept) |
11-deoxycorticosterone |
Acceptable (foundation metadata concept) |
11-deoxycorticosterone level above reference range |
Preferred (foundation metadata concept) |
11-deoxycorticosterone level above reference range (finding) |
Preferred (foundation metadata concept) |
11-deoxycorticosterone level below reference range |
Preferred (foundation metadata concept) |
11-deoxycorticosterone level below reference range (finding) |
Preferred (foundation metadata concept) |
11-deoxycorticosterone measurement |
Preferred (foundation metadata concept) |
11-deoxycorticosterone measurement (procedure) |
Preferred (foundation metadata concept) |
11-deoxycorticosterone within reference range |
Preferred (foundation metadata concept) |
11-deoxycorticosterone within reference range (finding) |
Preferred (foundation metadata concept) |
11-deoxycortisol |
Acceptable (foundation metadata concept) |
11-deoxycortisol challenge tests |
Preferred (foundation metadata concept) |
11-deoxycortisol challenge tests (procedure) |
Preferred (foundation metadata concept) |
11-deoxycortisol measurement |
Preferred (foundation metadata concept) |
11-deoxycortisol measurement (procedure) |
Preferred (foundation metadata concept) |
11-deoxysteroid |
Preferred (foundation metadata concept) |
11-deoxysteroid (substance) |
Preferred (foundation metadata concept) |
11-hydroxyandrostenedione measurement |
Preferred (foundation metadata concept) |
11-hydroxyandrostenedione measurement (procedure) |
Preferred (foundation metadata concept) |
11-hydroxyandrosterone |
Preferred (foundation metadata concept) |
11-hydroxyandrosterone (substance) |
Preferred (foundation metadata concept) |
11-hydroxyandrosterone measurement |
Preferred (foundation metadata concept) |
11-hydroxyandrosterone measurement (procedure) |
Preferred (foundation metadata concept) |
11-hydroxyetiocholanolone |
Preferred (foundation metadata concept) |
11-hydroxyetiocholanolone (substance) |
Preferred (foundation metadata concept) |
11-ketoandrosterone |
Preferred (foundation metadata concept) |
11-ketoandrosterone (substance) |
Preferred (foundation metadata concept) |
11-ketoandrosterone measurement |
Preferred (foundation metadata concept) |
11-ketoandrosterone measurement (procedure) |
Preferred (foundation metadata concept) |
11-ketoetiocholanolone |
Preferred (foundation metadata concept) |
11-ketoetiocholanolone (substance) |
Preferred (foundation metadata concept) |
11-ketoetiocholanolone measurement |
Preferred (foundation metadata concept) |
11-ketoetiocholanolone measurement (procedure) |
Preferred (foundation metadata concept) |
11-ketopregnanetriol |
Preferred (foundation metadata concept) |
11-ketopregnanetriol (substance) |
Preferred (foundation metadata concept) |
11-ketopregnanetriol measurement |
Preferred (foundation metadata concept) |
11-ketopregnanetriol measurement (procedure) |
Preferred (foundation metadata concept) |
11-oxo-etiocholanolone |
Preferred (foundation metadata concept) |
11-oxo-etiocholanolone (substance) |
Preferred (foundation metadata concept) |
11-oxo-pregnanetriol |
Preferred (foundation metadata concept) |
11-oxo-pregnanetriol (substance) |
Preferred (foundation metadata concept) |
11-oxoaetiocholanolone |
Acceptable (foundation metadata concept) |
11-oxoandrosterone |
Acceptable (foundation metadata concept) |
11-oxoetiocholanolone |
Acceptable (foundation metadata concept) |
11-oxopregnanetriol |
Acceptable (foundation metadata concept) |
11-oxy-17-ketosteroid |
Preferred (foundation metadata concept) |
11-oxy-17-ketosteroid (substance) |
Preferred (foundation metadata concept) |
11-oxycorticosteroid |
Preferred (foundation metadata concept) |
11-oxycorticosteroid (substance) |
Preferred (foundation metadata concept) |
11-oxycorticosterone |
Acceptable (foundation metadata concept) |
11-oxysteroid |
Acceptable (foundation metadata concept) |
11.2 |
Preferred (foundation metadata concept) |